Amgen SA

About Amgen SA

Amgen SA is a leading biotechnology company dedicated to the development and manufacturing of innovative therapies that address serious illnesses. Founded in 1980, Amgen has established itself as a pioneer in the field of biotechnology, focusing on the discovery of novel medicines based on human biology.

The company’s core activities include research, development, and commercialization of biologic therapies for various medical conditions, including cancer, kidney disease, and inflammatory disorders. Amgen is committed to advancing science and technology to improve patient outcomes and enhance the quality of life for individuals around the world.

With a strong emphasis on innovation, Amgen invests heavily in research and development, collaborating with academic institutions and other organizations to drive scientific breakthroughs. The company’s robust pipeline includes multiple products in various stages of clinical development, showcasing its dedication to addressing unmet medical needs.

Amgen operates globally, with a significant presence in the UK, where it contributes to the local economy through job creation and partnerships with healthcare providers. The company adheres to the highest standards of ethical practices and regulatory compliance, ensuring that its products are safe and effective for patients.

In addition to its focus on therapeutic advancements, Amgen is also committed to sustainability and corporate social responsibility. The company actively engages in initiatives aimed at reducing its environmental impact and supporting communities through health education and access to care.

Overall, Amgen SA stands at the forefront of biotechnology, driven by a mission to serve patients and transform the future of medicine.